A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

Summary

The study drug LY2393910 is being evaluated as a possible treatment for diabetes. The primary purpose of a patient's participation in this study is to help answer the following research question(s), and not to provide treatment for diabetes: * The safety of LY2393910 and any side effects that might be associated with it following 2 weeks of doses * How long it takes the body to absorb and remove LY2393910 following dosing over 2 weeks * How daily dosing of LY2393910 affects blood levels of sugar (glucose), insulin and other naturally occurring substances in your body * How daily dosing of LY2393910 affects the cells that produce insulin * Any differences in the above between LY2393910 taken as daily doses in the morning or in the evening

Timeline

Start

2010-03

Primary completion

2011-05

Completion

2011-05

Drugs

Indications